Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin

Journal of Neurology

Volumn 259, Issue 12, 2012, Pages 2538-2545

  Santamarina, E ^a   Penalba, A ^a   Garcia Berrocoso, T ^a   Delgado, P ^a   Quintana, M ^a   Gonzalez Alujas T ^a   Ribo, M ^a   Maisterra, O ^a   Molina, C A ^a   Evangelista, A ^a   Lvarez Sabin J A ^a   Montaner, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute stroke; Biomarkers; Echocardiography

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; D DIMER; MYOGLOBIN; TROPONIN;

ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HEART ANEURYSM; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SECOND HARMONIC TRANSTHORACIC ECHOCARDIOGRAPHY; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; STROKE PATIENT; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CREATINE KINASE, MB FORM; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK FACTORS; STROKE;

EID: 84872104265     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6532-4     Document Type: Article

References (37)

1. World Health Organization (2004) The global burden of disease (update 20080
2. Lovett JK, Coull AJ, Rothwell PM (2004) Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62:569-573
3. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41
4. Brott T, Bogousslavsky J (2000) Treatment of acute ischemic stroke. N Engl J Med 343:710-722
5. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a populationbased study. Stroke 32:2735-2740
6. Castellanos M, Serena J (2007) Applicability of biomarkers in ischemic stroke. Cerebrovasc Dis 24(suppl 1):7-15
7. Whiteley W, Tseng MC, Sandercock P (2008) Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke 39:2902-2909
8. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH (2009) Blood biomarkers in acute stroke. Neurology 73:393-399
9. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacón P, Rosell A et al (2008) Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39:2280-2287
10. Maisel A, Mueller C, Adams K Jr., Anker SD, Aspromonte N, Cleland JG et al (2008) State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10:824-839
11. Tombul T, Atbas C, Anlar O (2005) Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. J Clin Neurosci 12:429-434
12. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G et al (2002) Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 62:2589-2593
13. Furie KL, Rosenberg R, Thompson JL, Bauer K, Mohr JP, Rosner B et al (2004) Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology 63:777-784
14. The French Study of Aortic plaques in Stroke Group (1996) Aheroscletotic disease of the aortic arch as a risk factor for recurrent ischemic group. N Engl J Med 334:1216-1221
15. Shizabaki K, Kimura K, Iguchi Y, Okada Y, Inoue T (2009) Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 48:259-264
16. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6:92-96
17. Ohta Y, Shimada T, Yoshitomi H, Inoue S, Murakami Y, Shimizu H et al (2001) Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17:415-420
18. Hussein AA, Saliba WI, Martin DO, Shadman M, Kanj M, Bhargava M et al (2011) Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation 123:2077-2082
19. de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322
20. Shimizu H, Murakami Y, Inoue S, Ohta Y, Nakamura K, Katoh H et al (2002) High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 33:1005-1010
21. Naya T, Yukiiri K, Hosomi N, Takahashi T, Ohkita H, Mukai M et al (2008) Brain natriuretic peptide as a surrogate marker for cardiembolic stroke with paroxysmal atrial fibrillation. Cerebrovasc Dis 26:434-440
22. Okada Y, Shibazaki K, Kimura K, Iguchi Y, Miki T (2010) Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack. Eur J Neurol 17:326-331
23. Okada Y, Shibazaki K, Kimura K, Matsumoto N, Iguchi Y, Aoki J et al (2011) Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation. J Neurol Sci 301:86-89
24. Fromm RE Jr. (2007) Cardiac troponins in the intensive care unit: common causes of increased levels and interpretation. Crit Care Med 35:584-588
25. Ay H, Arsava EM, Saribaş O (2002) Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 33:286-289
26. Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, Falcou A et al (2005) Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76:76-81
27. Guerrero-Peral AB, Guerrero-Peral AL, Carrascal Y, Bustamante R, Rodríguez MA, Ponce-Villares MA et al (2002) Specific markers of myocardial injury in acute stroke. Rev Neurol 35:901-904
28. Tohgi H, Kawashima M, Tamura K, Suzuki H (1990) Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 21:1663-1667
29. Nakagawa K, Hirai T, Shinokawa N, Takashima S, Nozawa T, Asanoi H, Inoue H (2002) Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation. Chest 121:500-505
30. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S et al (1989) Hemorrhagic transformation in cerebral embolism. Stroke 20:598-603
31. de Abreu TT, Mateus S, Correia J (2005) Therapy implications of transthoracic echocardiography in acute ischemic stroke patients. Stroke 36:1565-1566
32. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A (2006) Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 37:859-864
33. de Bruijn S, Agema W, Lammers GJ, van der Wall E, Wolterbeek R, Holman E et al (2006) Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 37:2531-2534
34. Beattie JR, Cohen DJ, Manning WJ, Douglas PS (1998) Role of routine transthoracic echocardiography in evaluation and management of stroke. J Intern Med 243:281-291
35. Souteyrand G, Motreff P, Lusson JR, Rodriguez R, Geoffroy E, Dauphin C et al (2006) Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr 7:147-154
36. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D et al (2010) Stroke subtype classification to mechanismspecific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke 41:1579-1586
37. Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L (2006) Head to head comparison of N-terminal pro-Btype natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Clin Biochem 39:640-645